NewsRx

Search our medical news database

Opportunistic Infections (Kaposi's sarcoma)

Moderate Success Reported With Chemotherapy Regimen

Published in Cancer Weekly, May 27th, 1996

Italian researchers report a 55 percent response rate among HIV positive patients with Kaposi's sarcoma (KS) who underwent treatment with a new chemotherapy regimen.

Research results were reported in the May 15, 1996, issue of Cancer.

Dr. Marcello Tavio, of the Italian Cooperative Study Group on AIDS and Tumors, (GICAT) and colleagues evaluated the responses of 38 patients with progressive, extensive HIV related KS after treatment with doxorubicin, bleomycin and vindesine (ABVi).

"Vindesine was used instead of vincristine because of its lower neurotoxicity," Tavio explained.

Of the 21 patients who responded to...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook